Top 15 journals in Cancer Research

Journal of Clinical Oncology Q1

American Society of Clinical Oncology

The Journal of Clinical Oncology serves its readers as the single most credible, authoritative resource for disseminating significant clinical oncology research. In print and in electronic format, JCO strives to publish the highest quality articles dedicated to clinical research. Original Reports remain the focus of JCO, but this scientific communication is enhanced by appropriately selected Editorials, Commentaries, Reviews, and other work that relate to the care of patients with cancer.

Indexation

🛈 SJR Impact factor

10,054

🛈 Acceptance Rate

13 %

🛈 Time to publication

NPD

🛈 Inmediate OA:

3166 €

🛈 Embargoed OA:

NPD

🛈 Non OA:

- €

Cancer Research Q1

American Association for Cancer Research Inc.

Cancer Research publishes original studies, reviews, and opinion pieces offering significance and broad impact to a diverse audience. Cancer Research seeks manuscripts that offer pathobiological and translational impact to inform the personal, clinical, and societal problems posed by cancer.

Indexation

🛈 SJR Impact factor

4,051

🛈 Acceptance Rate

22 %

🛈 Time to publication

NPD

🛈 Inmediate OA:

4542 €

🛈 Embargoed OA:

NPD

🛈 Non OA:

1362 €

Nature Reviews Cancer Q1

Nature Publishing Group

Nature Reviews Cancer is a journal with an H index of 418. It is an CC BY journal with a Single blind Peer Review review system, and It has a price of…

Indexation

🛈 SJR Impact factor

21,287

🛈 Acceptance Rate

NPD

🛈 Time to publication

NPD

🛈 Inmediate OA:

NPD

🛈 Embargoed OA:

NPD

🛈 Non OA:

NPD

Journal of the National Cancer Institute Q1

Oxford University Press

Journal of the National Cancer Institute is a journal with an H index of 348. It is an journal with a Single blind Peer Review review system, and It has a price of…

Indexation

🛈 SJR Impact factor

5,356

🛈 Acceptance Rate

NPD

🛈 Time to publication

NPD

🛈 Inmediate OA:

3578 €

🛈 Embargoed OA:

NPD

🛈 Non OA:

0 €

Oncogene Q1

Nature Publishing Group

Oncogene aims to make substantial advances in our knowledge of processes that contribute to cancer by publishing outstanding research. We propagate work that challenges standard conjecture and builds on previous studies, in particular those that lead to establishing new paradigms in the etio-pathogenesis, diagnosis, treatment, or prevention of cancers, and in processes that drive metastatic spread, and provide important insights into cancer biology beyond what has been revealed thus far.

Indexation

🛈 SJR Impact factor

3,232

🛈 Acceptance Rate

NPD

🛈 Time to publication

NPD

🛈 Inmediate OA:

3490 €

🛈 Embargoed OA:

NPD

🛈 Non OA:

NPD

Cancer Cell Q1

Cell Press

Cancer Cell is a journal with an H index of 316. It is an CC BY-NC-ND journal with a Single blind Peer Review review system, and It has a price of…

Indexation

🛈 SJR Impact factor

11,909

🛈 Acceptance Rate

NPD

🛈 Time to publication

NPD

🛈 Inmediate OA:

4704 €

🛈 Embargoed OA:

NPD

🛈 Non OA:

NPD

Clinical Cancer Research Q1

American Association for Cancer Research Inc.

Clinical Cancer Research publishes innovative clinical and translational cancer research studies that bridge the laboratory and the clinic. The Journal is especially interested in clinical trials evaluating new treatments, accompanied by research on pharmacology, and molecular alterations or biomarkers that predict response or resistance to treatment. The Journal also prioritizes laboratory and animal studies of new drugs and molecule-targeted agents with the potential to lead to clinical trials

Indexation

🛈 SJR Impact factor

5,241

🛈 Acceptance Rate

NPD

🛈 Time to publication

NPD

🛈 Inmediate OA:

3500 €

🛈 Embargoed OA:

NPD

🛈 Non OA:

1500 €

Cancer Q1

John Wiley and Sons Inc.

Cancer is a journal with an H index of 292. It is an journal with a Single blind Peer Review review system, and It has a price of…

Indexation

🛈 SJR Impact factor

3,065

🛈 Acceptance Rate

NPD

🛈 Time to publication

NPD

🛈 Inmediate OA:

2500 €

🛈 Embargoed OA:

NPD

🛈 Non OA:

0 €

International Journal of Radiation Oncology Biology Physics Q1

Elsevier Inc.

International Journal of Radiation Oncology Biology Physics is a journal with an H index of 241. It is an CC BY-NC-ND journal with a Double blind Peer Review review system, and It has a price of…

Indexation

🛈 SJR Impact factor

2,096

🛈 Acceptance Rate

NPD

🛈 Time to publication

NPD

🛈 Inmediate OA:

NPD

🛈 Embargoed OA:

NPD

🛈 Non OA:

NPD

British Journal of Cancer Q1

Nature Publishing Group

British Journal of Cancer is a journal with an H index of 224. It is an CC BY journal with a Single blind Peer Review review system, and It has a price of…

Indexation

🛈 SJR Impact factor

2,445

🛈 Acceptance Rate

NPD

🛈 Time to publication

NPD

🛈 Inmediate OA:

2700 €

🛈 Embargoed OA:

NPD

🛈 Non OA:

NPD

International Journal of Cancer Q1

Wiley-Liss Inc.

International Journal of Cancer is a journal with an H index of 225. It is an journal with a Single blind Peer Review review system, and It has a price of…

Indexation

🛈 SJR Impact factor

2,154

🛈 Acceptance Rate

NPD

🛈 Time to publication

NPD

🛈 Inmediate OA:

3650 €

🛈 Embargoed OA:

NPD

🛈 Non OA:

0 €

PLoS Genetics Q1

Public Library of Science

Genetics and genomics research has grown at a bewildering pace in the past 15 years. The techniques of these fields are being applied to a wealth of biological questions and experimental systems. PLOS Genetics reflects the full breadth and interdisciplinary nature of this research by publishing outstanding original contributions in all areas of biology. PLOS Genetics publishes human studies, as well as research on model organisms—from mice and flies, to plants and bacteria.

Indexation

🛈 SJR Impact factor

3,744

🛈 Acceptance Rate

NPD

🛈 Time to publication

26 weeks

🛈 Inmediate OA:

2025 €

🛈 Embargoed OA:

NPD

🛈 Non OA:

- €

European Journal of Cancer Q1

Elsevier Ltd.

European Journal of Cancer is a journal with an H index of 205. It is an journal with a Single blind Peer Review review system, and It has a price of…

Indexation

🛈 SJR Impact factor

3,41

🛈 Acceptance Rate

NPD

🛈 Time to publication

NPD

🛈 Inmediate OA:

2655 €

🛈 Embargoed OA:

NPD

🛈 Non OA:

NPD

Carcinogenesis Q1

Oxford University Press

Carcinogenesis is a journal with an H index of 198. It is an journal with a Double blind peer review review system, and It has a price of…

Indexation

🛈 SJR Impact factor

1,661

🛈 Acceptance Rate

NPD

🛈 Time to publication

NPD

🛈 Inmediate OA:

3154 €

🛈 Embargoed OA:

NPD

🛈 Non OA:

NPD

Leukemia Q1

Nature Publishing Group

Leukemia publishes high quality, peer reviewed research that covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance. Topics of interest include oncogenes, growth factors, stem cells, leukemia genomics, cell cycle, signal transduction, molecular targets for therapy and more. We publish a range of content types including original research articles, reviews, letters, correspondence and commen

Indexation

🛈 SJR Impact factor

3,966

🛈 Acceptance Rate

NPD

🛈 Time to publication

NPD

🛈 Inmediate OA:

3966 €

🛈 Embargoed OA:

NPD

🛈 Non OA:

Top 15 journals in Cancer Research

3166 €

NPD

- €

4542 €

NPD

1362 €

NPD

NPD

NPD

3578 €

NPD

0 €

3490 €

NPD

NPD

4704 €

NPD

NPD

3500 €

NPD

1500 €

2500 €

NPD

0 €

NPD

NPD

NPD

2700 €

NPD

NPD

3650 €

NPD

0 €

2025 €

NPD

- €

2655 €

NPD

NPD

3154 €

NPD

NPD

3966 €

NPD

2474 €